BPA
CVS icon

Beacon Pointe Advisors’s CVS Health CVS Stock Holding History

Beacon Pointe Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Buy
26,995
+10,121
+60% +$780K 0.01% 742
2025
Q4 		$1.34M Sell
16,874
-363
-2% -$28.6K 0.01% 737
2025
Q3 		$1.3M Sell
17,237
-1,235
-7% -$84.6K 0.01% 669
2025
Q2 		$1.27M Buy
18,472
+531
+3% +$34.8K 0.01% 591
2025
Q1 		$1.22M Sell
17,941
-2,037
-10% -$122K 0.01% 581
2024
Q4 		$897K Sell
19,978
-17,091
-46% -$959K 0.01% 661
2024
Q3 		$2.33M Sell
37,069
-9,964
-21% -$581K 0.03% 435
2024
Q2 		$2.78M Sell
47,033
-8,603
-15% -$538K 0.03% 413
2024
Q1 		$4.44M Sell
55,636
-8,895
-14% -$679K 0.05% 314
2023
Q4 		$5.1M Sell
64,531
-4,135
-6% -$294K 0.06% 281
2023
Q3 		$4.79M Buy
68,666
+12,840
+23% +$910K 0.06% 269
2023
Q2 		$3.86M Sell
55,826
-11,871
-18% -$845K 0.06% 258
2023
Q1 		$5.03M Buy
67,697
+6,319
+10% +$530K 0.09% 215
2022
Q4 		$5.72M Buy
61,378
+5,524
+10% +$533K 0.11% 173
2022
Q3 		$5.33M Sell
55,854
-1,040
-2% -$103K 0.12% 165
2022
Q2 		$5.27M Sell
56,894
-25,713
-31% -$2.51M 0.11% 175
2022
Q1 		$8.36M Buy
82,607
+53,382
+183% +$5.61M 0.11% 179
2021
Q4 		$3.02M Sell
29,225
-6,797
-19% -$628K 0.08% 196
2021
Q3 		$3.06M Buy
36,022
+13,516
+60% +$1.13M 0.08% 223
2021
Q2 		$1.88M Buy
22,506
+14,821
+193% +$1.21M 0.07% 232
2021
Q1 		$577K Sell
7,685
-1,544
-17% -$112K 0.04% 274
2020
Q4 		$630K Buy
9,229
+2,106
+30% +$137K 0.04% 243
2020
Q3 		$416K Buy
7,123
+248
+4% +$15.4K 0.04% 250
2020
Q2 		$447K Buy
6,875
+1,642
+31% +$103K 0.04% 250
2020
Q1 		$312K Buy
5,233
+2,389
+84% +$159K 0.05% 231
2019
Q4 		$211K Buy
+2,844
New +$200K 0.07% 209

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Beacon Pointe Advisors's CVS Position: Q1 2026 in Review

Beacon Pointe Advisors increased its CVS Health (CVS) stake by 60% in Q1 2026, buying an estimated $780K and bringing the position to 26,995 shares worth $1.94M. The position accounts for 0.01% of the portfolio, ranked #742.

Beacon Pointe Advisors first reported a position in CVS in Q4 2019 and has held it in 26 quarters since. The position peaked at $8.36M in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Beacon Pointe Advisors held 26,995 shares of CVS Health worth $1.94M as of Q1 2026.
  • Beacon Pointe Advisors bought 10,121 CVS Health shares in Q1 2026, an estimated $780K.
  • CVS Health made up 0.01% of Beacon Pointe Advisors's portfolio in Q1 2026, its #742 holding.
  • Beacon Pointe Advisors first reported a position in CVS Health in Q4 2019 and has held it in 26 quarters since.
  • Beacon Pointe Advisors's CVS Health position peaked at $8.36M in Q1 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Beacon Pointe Advisors's 13F filing for Q1 2026, filed 15 May 2026.